Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV
MAPS
Managed Problem Solving: An HIV Adherence Trial
2 other identifiers
interventional
180
1 country
1
Brief Summary
This study will determine whether a managed problem solving intervention can help patients with HIV better follow their anti-HIV drug regimen and can control HIV better than the standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv-infections
Started Jul 2005
Longer than P75 for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 11, 2005
CompletedFirst Posted
Study publicly available on registry
August 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedJuly 13, 2012
July 1, 2012
5.6 years
August 11, 2005
July 12, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improved adherence
Measured at Year 4
Secondary Outcomes (2)
Decrease in viral load
Measured at Year 4
Increase in CD4 count
Measured at Year 4
Study Arms (2)
1
EXPERIMENTALParticipants will receive managed problem solving for 12 months
2
ACTIVE COMPARATORParticipants will receive standard of care for 12 months
Interventions
Participants in the managed problem solving group will have four study visits and will receive three phone calls for the first 3 months of the study, and one phone call every month for the following 9 months. At each study visit, participants will identify barriers to adherence. During the phone calls, participants will be asked about any steps they have taken to improve their adherence. A medication event monitoring system (MEMS) will be used to assess participants' treatment adherence. MEMS uses microelectronic monitors on the caps of medication bottles to record the timing and frequency of bottle openings. Participants whose adherence has decreased or remained the same at the end of 12 months will be evaluated for regimen changes. Blood collection at the beginning and end of the study will be used to measure viral load and CD4 count.
Eligibility Criteria
You may qualify if:
- HIV infected
- Infection likely to be susceptible to a specific treatment regimen
- Have access to a telephone
- Willing and able to comply with all study requirements
You may not qualify if:
- Live in a care facility that provides medications on schedule
- Restarting HAART after a treatment interruption of at least 3 months OR after virologic failure with a viral load greater than 1,000 copies/ml
- On a treatment regimen for less than 2 weeks prior to study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Gross R, Bellamy SL, Chapman J, Han X, O'Duor J, Palmer SC, Houts PS, Coyne JC, Strom BL. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med. 2013 Feb 25;173(4):300-6. doi: 10.1001/jamainternmed.2013.2152.
PMID: 23358784DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Gross, MD, MSCE
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine and Epidemiology
Study Record Dates
First Submitted
August 11, 2005
First Posted
August 15, 2005
Study Start
July 1, 2005
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
July 13, 2012
Record last verified: 2012-07